BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 7949203)

  • 1. Aromatase inhibitors--mechanisms of steroidal inhibitors.
    Brueggemeier RW
    Breast Cancer Res Treat; 1994; 30(1):31-42. PubMed ID: 7949203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring new chemical functionalities to improve aromatase inhibition of steroids.
    Varela CL; Amaral C; Correia-da-Silva G; Costa SC; Carvalho RA; Costa G; Alcaro S; Teixeira NA; Tavares-da-Silva EJ; Roleira FM
    Bioorg Med Chem; 2016 Jun; 24(12):2823-31. PubMed ID: 27160054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aromatase, aromatase inhibitors, and breast cancer.
    Brueggemeier RW
    Am J Ther; 2001; 8(5):333-44. PubMed ID: 11550075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemistry and pharmacology of 7alpha-substituted androstenediones as aromatase inhibitors.
    Brueggemeier RW; O'Reilly JM; Lovely CJ; Ward PJ; Quinn AL; Baker D; Darby MV; Gu XJ; Gilbert NE
    J Steroid Biochem Mol Biol; 1997 Apr; 61(3-6):247-54. PubMed ID: 9365197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Development of aromatase inhibitors and analysis of their inhibitory activities].
    Numazawa M
    Yakugaku Zasshi; 1998 Dec; 118(12):539-53. PubMed ID: 9921263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and synthesis of new steroidal inhibitors of estrogen synthase (aromatase).
    Parish EJ; Li S; Rao Z
    Lipids; 2000 Mar; 35(3):271-7. PubMed ID: 10783004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aromatase, its inhibitors and their use in breast cancer treatment.
    Brodie AM
    Pharmacol Ther; 1993 Dec; 60(3):501-15. PubMed ID: 8073072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological profiles of exemestane and formestane, steroidal aromatase inhibitors used for treatment of postmenopausal breast cancer.
    Lønning PE
    Breast Cancer Res Treat; 1998; 49 Suppl 1():S45-52; discussion S73-7. PubMed ID: 9797017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological characterization of A-ring steroids.
    Johnston JO; Wright CL; Burkhart JP; Peet NP
    J Steroid Biochem Mol Biol; 1993 Mar; 44(4-6):623-31. PubMed ID: 8476773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aromatase inhibition by 7-substituted steroids in human choriocarcinoma cell culture.
    Brueggemeier RW; Katlic NE; Kenreigh CA; Li PK
    J Steroid Biochem Mol Biol; 1992 Jan; 41(1):85-90. PubMed ID: 1734938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aromatase inhibitors: new endocrine treatment of breast cancer.
    Brueggemeier RW
    Semin Reprod Med; 2004 Feb; 22(1):31-43. PubMed ID: 15083379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probing the binding pocket of the active site of aromatase with 6-ether or 6-ester substituted androst-4-ene-3,17-diones and their diene and triene analogs.
    Numazawa M; Shelangouski M; Nagasaka M
    Steroids; 2000 Dec; 65(12):871-82. PubMed ID: 11077085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An efficient steroid pharmacophore-based strategy to identify new aromatase inhibitors.
    Neves MA; Dinis TC; Colombo G; Sá e Melo ML
    Eur J Med Chem; 2009 Oct; 44(10):4121-7. PubMed ID: 19500885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mechanisms of aromatase inhibition by new A, D-ring modified steroids.
    Cepa M; Correia-da-Silva G; Tavares da Silva EJ; Roleira FM; Hong Y; Chen S; Teixeira NA
    Biol Chem; 2008 Sep; 389(9):1183-91. PubMed ID: 18713005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exemestane, a new steroidal aromatase inhibitor of clinical relevance.
    Lombardi P
    Biochim Biophys Acta; 2002 Jul; 1587(2-3):326-37. PubMed ID: 12084475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aromatase and its inhibitors in breast cancer treatment--overview and perspective.
    Brodie AM; Santen RJ
    Breast Cancer Res Treat; 1994; 30(1):1-6. PubMed ID: 7949200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probing the active site of aromatase with 2-methyl-substituted androstenedione analogs.
    Numazawa M; Watari Y; Yamada K; Umemura N; Handa W
    Steroids; 2003 Aug; 68(6):503-13. PubMed ID: 12906935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Progress in study of the structure, catalytic mechanism and inhibitors of aromatase].
    Fu J; Shen ZH; Cheng FX; Liu GX; Li WH; Tang Y
    Yao Xue Xue Bao; 2012 Jan; 47(1):18-28. PubMed ID: 22493800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aromatase inhibitors in the treatment of breast cancer.
    Brueggemeier RW; Hackett JC; Diaz-Cruz ES
    Endocr Rev; 2005 May; 26(3):331-45. PubMed ID: 15814851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding features of steroidal and nonsteroidal inhibitors.
    Hong Y; Rashid R; Chen S
    Steroids; 2011 Jul; 76(8):802-6. PubMed ID: 21420422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.